SOSV Announces Launch of IndieBio New York

A  fantastic opportunity for life science startups in the New York area!

“We’re doubling down on life sciences,” said Sean O’Sullivan, Managing General Partner of SOSV. “We are looking to bring what IndieBio has created for the California life science industry to the East Coast. New York is a great hub for life sciences research and financing, and will be a natural center for life science startups.”

Google Shows AI Can Spot Breast Cancer Better Than Doctors

According to new research from Google Health, AI can more accurately detect breast cancer than physicians.

"The technology’s reading of mammograms reduced both false positives, where healthy patients are mistakenly diagnosed with the disease, and false negatives, where the cancer is missed, the Alphabet Inc. unit said in a blog post on Wednesday. The system reduced false positives by 5.7% in the U.S., according to data from more than 28,000 mammograms performed there and in the U.K."

New radiotracer offers opportunities for earlier intervention after heart attack

“ Reston, VA–Insights into how the heart recovers after myocardial infarction (heart attack) can be obtained with a new radiotracer that targets fibroblast activity prior to it causing permanent damage. According to research published in the December issue of The Journal of Nuclear Medicine, 68Ga-FAPI-04 positron emission tomography (PET) can effectively image fibroblast activation after myocardial infarction, identifying a time window during which cardiac fibrosis can be prevented and the disease course altered.“

Ochsner Health System and Pfizer Partner to Develop Innovative Models for Clinical Trials

Sponsors and technology vendors need to work together to develop innovative new ways to streamline the clinical trial process

Ochsner Health System and Pfizer have embarked on a multi-year alliance to enhance the clinical trial experience and ease participation in clinical research for both patients and healthcare professionals.